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Background: Cough is a frequent symptom of cigarette smokers that often precedes the devel-
opment of airflow obstruction. We determined whether chronic cigarette smoking is associated
with an increase in capsaicin cough response in the absence of cough.
Methods: We examined this in asymptomatic smokers with normal lung function (nZ 68, FEV1
99.3  2.1% predicted) and in patients with established COPD without cough symptoms
(nZ 42; FEV1 57.0  2.6% predicted), using healthy non-smoking volunteers as control
(nZ 92; FEV1 100.6  1.7% predicted). Using an incremental capsaicin concentration chal-
lenge protocol, we recorded the concentrations that induced 2 (C2) and 5 or more coughs (C5).
Results: Because females have a lower C2 and C5 than males in the control group, we analysed
the data in each group according to gender. Log C5 was decreased both in asymptomatic
smokers (1.56  0.11 mmol/L, p < 0.05) and in COPD patients (1.44  0.14 mmol/L, p < 0.01)
when compared to non-smokers (1.90  0.09 mmol/L). Log C2 did not differ between groups.
Log C2 and log C5 were decreased in women (0.772  0.071 mmol/L and 1.481  0.094 mmol/
L, respectively) when compared to men (1.045  0.088 mmol/L and 1.923  0.087 mmol/L,
respectively) (p < 0.05 for log C2; p < 0.001 for log C5).
Conclusion: We conclude that chronic cigarette smoking increases capsaicin cough reflex and
that this remains so with the development of COPD.
ª 2008 Elsevier Ltd. All rights reserved.ive pulmonary disease; C2, concentration of capsaicin required to induce 2 coughs; C5, concentration
ore coughs; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.
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Cough is a frequent symptom of cigarette smokers and is
often the first symptom of disease that precedes the
development of airflow obstruction. Cough and sputum
production for at least 3 months of the year in 2 consecu-
tive years is used to define chronic bronchitis and are
usually prominent features of early disease resulting from
chronic cigarette smoking. There is now increasing
evidence that chronic mucus hypersecretion may have an
effect on decline in lung function.1,2 The potential mech-
anisms of cough induced by cigarette smoking are
numerous. Inflammatory mechanisms induced by constitu-
ents of cigarette smoke may lead to heightened cough
reflex sensitivity, and excessive mucus production may
directly induce cough. Cigarette smoke-exposed guinea-
pigs develop an enhanced cough reflex to citric acid or
capsaicin.3
In humans, cough responsiveness is usually studied by
the inhalation of aerosols of irritant substances that stim-
ulate cough, e.g. citric acid or capsaicin. Although these
challenges have not gained widespread use in clinical
monitoring, they are used as a research tool.4 Using
capsaicin cough challenge, an increased cough reflex was
described in COPD patients as compared to a non-smoking
normal population.5 Paradoxically, in a small group of
healthy cigarette smokers, a decrease in capsaicin cough
reflex was reported, which was ascribed to increased mucus
that would prevent stimulation of cough by restricting the
access of capsaicin to the cough receptor.6 Discrepancies
exist between data of cough challenges obtained with citric
acid and capsaicin in COPD patients in that there was
a lower threshold to citric acid without concomitant change
in capsaicin threshold.7 One of the potential reasons for
these discrepant results could be accounted for by the
effect of airflow obstruction itself.
In the present study, we therefore tested the hypothesis
that cigarette smoking enhances cough reflex sensitivity
before having any significant impact on airflow obstruction.
We used capsaicin challenge because this extract of red
pepper induces cough in a dose-dependent and reproduc-
ible fashion and has over the years become the preferred
agent for measurement of cough responsiveness thanks to
its safety and minimal degree of tachyphylaxis.8 In order to
determine further the role of cough reflex in cigarette
smoking, we examined capsaicin cough responsiveness in
a cohort of 92 non-smoking and 110 smoking subjects of
whom 68 had normal spirometric measurements and 42 had
established COPD. Our data indicates that cough respon-
siveness is enhanced both in asymptomatic smokers with
preserved lung function and in COPD patients with airflow
obstruction.
Materials and methods
Study subjects
Asymptomatic adult smokers and healthy non-smokers not
on any medication were recruited by advertisement. Adult
smokers with COPD (defined as a FEV1/FVC ratio <0.70)
were recruited from the Royal Brompton Hospital clinicsand were studied during a period of stability defined by no
changes in symptoms for 4 weeks and no use of antibiotics
or oral corticosteroids for 12 weeks. All smokers were
smoking regularly at the time of study and none were on
smoking cessation programmes or had tried to stop smoking
in the past year. The non-smokers had never smoked in the
past and were not exposed to secondary smoke. Most of the
COPD patients were treated with short-acting bronchodi-
lators and nearly half of them with inhaled corticosteroids
and/or long-acting bronchodilators. Patients with a history
of asthma were excluded. None of the patients or volun-
teers complained of a chronic cough. The study was
approved by the Ethics Committee of the Royal Brompton
and Harefield Trust and informed consent was obtained
from each volunteer.
Measurements
Smokers were instructed not to smoke within 60 min of
cough challenge and all subjects were asked not to take
food or to do exercise also 60 min prior to challenge. No
drinks containing caffeine were allowed for 4 h prior to
cough challenge. Forced expiratory volume in 1 s (FEV1) and
forced vital capacity (FVC) were first measured in all
subjects using a dry wedge spirometer (Vitalograph, Buck-
ingham, UK).
Capsaicin cough challenge was performed by inhalation
of incrementally doubling concentrations of capsaicin
(0.9765e500 mmol/L), as previously described.9 Capsaicin
(8-Methyl-N-Vanillyl-6-Nonenamide; Sigma UK) was
prepared as a 102 M stock solution in 100% ethanol stored
at 20 C. Fresh dilutions were made from this stock solu-
tion in 0.9% NaCl on a daily basis and stored at 4 C. Two ml
of solution were placed in a breath-activated nebuliser with
a dosimeter (Mefar Dosimeter, Mefar, Italy) that was driven
at a pressure of 151 kPa for a period of 1 s. Each puff
delivered 20 ml, with a particle size of 4 mm mass median
aerodynamic diameter at 1 min intervals. Patients were
instructed to inspire from functional residual capacity to
total lung capacity at a flow rate to trigger the dosimeter.
They were asked to cough freely and the number of coughs
induced during the 1 min period after capsaicin adminis-
tration was counted, although most of the coughs occurred
within 10 sof inhalation. The concentration of capsaicin
required to induce 2 coughs (C2) or 5 coughs (C5) or more
was recorded. The test was stopped when either C5 was
obtained or when the highest capsaicin concentration
(500 mmol/L) was reached without triggering more than 5
coughs. In the latter situation, the test was considered
negative and an arbitrary value of 1000 was assigned. C2
and C5 values were converted to logC2 and logC5, respec-
tively, for analysis.
Statistical analysis
Data are expressed as means  SEM. Statistical analyses
were performed using StatView version 5.0. Unpaired
t-tests were used to analyse differences in quantitative
data (age, log C2, log C5, FEV1, FVC) between groups and
the chi-square test was used to analyse dichotomous data.
Correlation between two variables was calculated by linear
Table 1 Characteristics of normal volunteers and smokers.
Non-smokers
(nZ 92)
Asymptomatic smokers
(nZ 68)
COPD patients
(nZ 42)
Male/female 43/49 30/38 22/20
Age, years (range) 34  1 (21e87) 38  2* (21e79) 64  2** (37e84)
Height, cm 171.3  0.9 169.4  1.3 169.7  1.4
Smoking status,
pack years
0  0 15.6  1.8** 38.9  3.1**
FEV1 (L) 3.59  0.09 3.35  0.11 1.54  0.09**
FEV1 (% pred.) 100.6  1.7 99. 3  2.1 57.0  2.6**
FVC (L) 4.22  0.11 4.07  0.13 2.77  0.14**
FVC (% pred.) 100.8  1.6 102.6  2.1 82.9  3.2**
FEV1/FVC 85.2  0.6 82.4  0.8* 55.5  1.5**
*: p < 0.05 vs. non-smokers. **: p < 0.01 vs. non-smokers. Values are means  SEM.
788 F.-X. Blanc et al.regression using the least-squares method. p < 0.05 was
considered statistically significant.
Results
Baseline characteristics of the patients are given in Table 1.
Among COPD patients, 3 patients were classified as stage 1,
25 patients as stage 2, 12 patients as stage 3 and 2 patients
as stage 4 according to the GOLD criteria.10
There were no unexpected adverse events reported. The
capsaicin challenge was negative in 29 subjects (15 non-
smokers, 10 asymptomatic smokers and 4 COPD). Compared
to non-smokers, log C5 was lower in both asymptomatic
smokers and in COPD patients (Fig. 1). However, there were
no differences regarding the C2 values. The distribution of
the log C5 values is shown in Fig. 2 with respect to FEV1.
There was no significant correlation between log C5 and
either FEV1 or FVC or FEV1/FVC.0.0
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Figure 1 Log C2 and log C5 in non-smokers (nZ 92),
asymptomatic smokers (nZ 68) and COPD patients (nZ 42).
Values are means  SEM. C2: concentration of capsaicin
required to induce 2 coughs. C5: concentration of capsaicin
required to induce 5 or more coughs.One factor influencing C5 (but not C2) was age. Log C5
was 1.806  0.076 mmol/L in patients <50 years old vs.
1.403  0.127 mmol/L in patients 50 years old (p < 0.01).
Another factor influencing C5 as well as C2 was gender
(Table 2). Log C2 was 0.772  0.071 mmol/L in female vs.
1.045  0.088 mmol/L in male (p < 0.05) while log C5 was
1.481  0.094 mmol/L in female vs. 1.923  0.087 mmol/L in
male (p < 0.001).
Discussion
We have shown in this large cross-sectional study of chronic
cigarette smokers that capsaicin cough sensitivity was
increased in asymptomatic smokers compared to non-
smoking controls in both male and female subjects. In
comparison to non-smoking controls but not to asymptom-
atic smokers, there was an increase in capsaicin cough
sensitivity in COPD patients, again shown in both genders.
Therefore, capsaicin cough sensitivity increases with ciga-
rette smoking irrespective of the development of COPD. We
analysed our data according to gender since there is
a known difference in capsaicin cough sensitivity with0
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Figure 2 Relationship between FEV1 (% predicted) and log C5
for non-smokers (B), asymptomatic smokers ), and patients
with COPD ( ). There was no significant correlation. C5:
concentration of capsaicin required to induce 5 or more coughs
(For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this
article).
Table 2 Gender-related differences in log C2 and log C5.
Male Female p value
Non-smokers n 43 49
Log C2 0.998  0.124 0.844  0.124 NS
Log C5 2.111  0.115 1.710  0.144 0.04
Asymptomatic
smokers
n 30 38
Log C2 1.013  0.156 0.695  0.105 0.08
Log C5 1.796  0.159 1.376  0.159 0.07
COPD n 22 20
Log C2 1.180  0.203 0.742  0.119 0.08
Log C5 1.727  0.204 1.119  0.172 0.03
Values are means  SEM.
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with log C5 measurements. The differences in capsaicin
cough sensitivity between men and women were main-
tained in all 3 groups studied, with women being more
sensitive than men in all cases.
Our data are in agreement with those of Doherty et al.5
who reported the presence of an increased cough reflex as
measured by capsaicin responsiveness in patients with
COPD, when compared to normal non-smoking subjects.
The effect of smoking alone was not studied. We therefore
extended these observations since we also found that
capsaicin responsiveness was increased in smoking asymp-
tomatic volunteers indicating that this increase was related
to the effect of cigarette smoking rather than the devel-
opment of COPD. Another important difference is that the
asymptomatic smokers did not complain of cough despite
an increase in capsaicin sensitivity, and it is possible that
the degree of cough hypersensitivity was not large enough
to lead to persistent cough. Similar to the findings of Doh-
erty et al., we found no correlation between cough sensi-
tivity and the degree of airflow obstruction in COPD as
measured by FEV1. Our results are on the other hand
different from those of Wong and Morice7 who reported no
significant differences in capsaicin cough sensitivity in 16
COPD patients while citric acid cough sensitivity was
increased. On the other hand, in 20 male current smokers,
a diminution of capsaicin cough sensitivity compared to
non-smoking control subjects has been reported.6
Furthermore, the same group reported that cessation of
smoking led to a reduction of capsaicin cough sensitivity.13
Our data indicates that both male and female smokers
maintain increased capsaicin cough sensitivity when
compared to their respective controls, irrespective of
gender. It remains difficult to reconcile these latter studies
with ours and that of Doherty et al.5 since all studies used
similar methodologies for the capsaicin cough challenge.
We found that the C2 values did not show any differ-
ences between the groups, while the C5 values were
consistently lower in the smoking groups that we studied.
Another factor that relates to capsaicin cough responsive-
ness is age since we found that normal volunteers >50 years
have a more sensitive cough reflex than those <50 years.
This would suggest that the cough reflex increases with age,
and may act as an improved protective reflex against
aspiration which occurs more frequently in the elderly.
The increase in capsaicin cough responsiveness in cigarette
smokers may relate to the degree of inflammatory responseinduced by chronic exposure to cigarette smoke. In guinea-
pigs, exposure to cigarette smoke enhances capsaicin and
citric acid cough responsiveness, an effect associated with an
increase in the expression of CGRP-containing sensory
nerves.14 A dual neurokinin receptor antagonist that blocks
both NK-1 and NK-2 receptors has been shown to inhibit the
hypertussive citric acid response following cigarette smoking
exposure in guineapigs.3 Mutoh et al. showed that sensitisa-
tion of bronchopulmonary C-fibres endings by chronic expo-
sure to side stream tobacco smoke was transmitted to the
nucleus tractus solitarius and was associated with prolonged
reflex evoked expiratory apnoea.15 Further work by this
group16 showed that in young guinea-pigs exposed to envi-
ronmental tobaccosmoke, therewasan increase incitric acid-
induced cough through an NK-1 receptor mechanism in the
brain stem nucleus tractus solitarius.
In summary, usingan incremental capsaicin concentration
challenge protocol, we found that the concentration that
induced 5 or more coughs (C5) was decreased both in
asymptomatic smokers and in COPD patientswhen compared
to non-smokers. Cough reflex sensitivity assessed by C5 was
affected by both age and gender. We suggest that an early
effect of cigarette smoking is to increase capsaicin cough
reflex sensitivity and that the development of COPD is not
associated with a further increase in the cough reflex.
However, longitudinal studies will be needed to confirm this
hypothesis.
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